We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRI icon
3251
Darden Restaurants
DRI
$24.4B
$2K ﹤0.01%
18
-3,341
-99% -$398K
DSL
3252
DoubleLine Income Solutions Fund
DSL
$1.24B
$2K ﹤0.01%
+100
New +$2.02K
EB
3253
DELISTED
Eventbrite
EB
$2K ﹤0.01%
100
-8,490
-99% -$158K
AXIA
3254
AXIA Energia
AXIA
$2K ﹤0.01%
+212
New +$1.45K
EMB icon
3255
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$2K ﹤0.01%
+17
New +$1.87K
EPSN icon
3256
Epsilon Energy
EPSN
$173M
$2K ﹤0.01%
+634
New +$2.65K
ESGE icon
3257
iShares ESG Aware MSCI EM ETF
ESGE
$6.73B
$2K ﹤0.01%
72
-1,081
-94% -$36.5K
EWZS icon
3258
iShares MSCI Brazil Small-Cap ETF
EWZS
$221M
$2K ﹤0.01%
+93
New +$1.45K
FBIZ icon
3259
First Business Financial Services
FBIZ
$595M
$2K ﹤0.01%
100
-236
-70% -$5.36K
FBIN icon
3260
Fortune Brands Innovations
FBIN
$6.06B
$2K ﹤0.01%
46
-9,449
-100% -$420K
FCAP icon
3261
First Capital
FCAP
$214M
$2K ﹤0.01%
40
+33
+471% +$1.66K
FET icon
3262
Forum Energy Technologies
FET
$835M
$2K ﹤0.01%
25
-402
-94% -$38.3K
KYNB
3263
Kyntra Bio
KYNB
$29.4M
$2K ﹤0.01%
2
-25
-93% -$27.4K
FIVN icon
3264
FIVE9
FIVN
$2.54B
$2K ﹤0.01%
39
-4
-9% -$203
FORTY
3265
Formula Systems
FORTY
$1.67B
$2K ﹤0.01%
30
-13
-30% -$631
FUNC icon
3266
First United
FUNC
$289M
$2K ﹤0.01%
+100
New +$1.85K
CBIO
3267
Crescent Biopharma
CBIO
$626M
$2K ﹤0.01%
2
-12
-86% -$14.3K
HES
3268
DELISTED
Hess
HES
$2K ﹤0.01%
36
-6,058
-99% -$375K
HSIC icon
3269
Henry Schein
HSIC
$9.82B
$2K ﹤0.01%
26
-5,404
-100% -$357K
IGF icon
3270
iShares Global Infrastructure ETF
IGF
$10.8B
$2K ﹤0.01%
+43
New +$1.95K
IGSB icon
3271
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$2K ﹤0.01%
37
-34
-48% -$1.8K
IHY icon
3272
VanEck International High Yield Bond ETF
IHY
$43.4M
$2K ﹤0.01%
100
INOD icon
3273
Innodata
INOD
$2.04B
$2K ﹤0.01%
1,998
-942
-32% -$1.03K
IRWD icon
3274
Ironwood Pharmaceuticals
IRWD
$714M
$2K ﹤0.01%
+185
New +$2.07K
JVA icon
3275
Coffee Holding Co
JVA
$20M
$2K ﹤0.01%
379
+331
+690% +$1.59K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.